Salim Haffar, PCI Pharma Services CEO

PCI Phar­ma Ser­vices to in­vest $50M to boost pro­duc­tion at Illi­nois cam­pus

Philadel­phia-based con­tract man­u­fac­tur­er PCI Phar­ma an­nounced on Tues­day plans to in­vest $50 mil­lion to build a new 200,000-square-foot man­u­fac­tur­ing fa­cil­i­ty at its cam­pus in the city of Rock­ford, Illi­nois.

Ac­cord­ing to a state­ment from the com­pa­ny, the new fa­cil­i­ty will have over 20 man­u­fac­tur­ing suites and the abil­i­ty to as­sem­ble and pack­age vials, pre-filled sy­ringes and oth­er in­jectable med­i­cines. It will al­so pro­duce med­i­cines de­signed to treat di­a­betes and obe­si­ty as well as man­u­fac­ture drugs for on­col­o­gy and au­toim­mune dis­eases.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.